Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Plasma cell 4Other hematologic neoplasm 4Other neoplasm 3Dermatologic 3Classical hematology 3Thoracic 1Breast 1

Conditions

Lung Neoplasms 4Anemia 4Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Small Cell Lung Carcinoma 1Pleural Effusion, Malignant 1Pleural Effusion 1Neutropenia 1Multiple Myeloma 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 8Nivolumab 6Gemcitabine 5spartalizumab 3Magnetic Resonance Spectroscopy 3Cyclophosphamide 3Azacitidine 3toripalimab 2fludarabine 2epacadostat 2atezolizumab 2Therapeutics 2Sirolimus 2Paclitaxel 2Interleukin-2 2Epoetin Alfa 2Cisplatin 2Bevacizumab 2vocimagene amiretrorepvec 1vandetanib 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tislelizumab 1temsirolimus 1sargramostim 1sapanisertib 1ruxolitinib 1rucaparib 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Darbepoetin alfa × Thoracic × Clear all
NCT00036023 2009-05-11

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Amgen

Phase 2 Completed
BreastLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡